---
title: "Boralex (TSE:BLX) Share Price Crosses Above Two Hundred Day Moving Average   - Should You Sell?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294922798.md"
description: "Boralex (TSE:BLX) shares crossed above their 200-day moving average, trading at C$37.09. Analysts revised price targets, with RBC raising its to C$37.25 and Raymond James lowering it to C$37.25. The consensus rating is a 'Moderate Buy' with a target of C$38.39. Boralex recently reported quarterly earnings of C$(0.08) per share on C$286 million revenue and announced a C$0.165 quarterly dividend."
datetime: "2026-08-05T07:00:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294922798.md)
  - [en](https://longbridge.com/en/news/294922798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294922798.md)
generator: "portal-rs"
---

# Boralex (TSE:BLX) Share Price Crosses Above Two Hundred Day Moving Average   - Should You Sell?

Boralex Inc. (TSE:BLX - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$33.49 and traded as high as C$37.13. Boralex shares last traded at C$37.09, with a volume of 341,419 shares trading hands.

## Analysts Set New Price Targets

A number of research firms have weighed in on BLX. Royal Bank Of Canada raised their price target on Boralex from C$33.00 to C$37.25 and gave the company a "sector perform" rating in a research note on Tuesday, May 12th. Raymond James Financial cut Boralex from an "outperform" rating to a "market perform" rating and lowered their price objective for the stock from C$38.00 to C$37.25 in a research report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of C$38.39.

**View Our Latest Analysis on BLX**

## Boralex Price Performance

The company has a debt-to-equity ratio of 309.98, a current ratio of 1.24 and a quick ratio of 1.53. The company has a 50 day moving average price of C$36.96 and a 200 day moving average price of C$33.49. The firm has a market cap of C$3.81 billion, a PE ratio of -119.65, a PEG ratio of 2.01 and a beta of 0.20. 

Boralex (TSE:BLX - Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported C($0.08) earnings per share for the quarter. The firm had revenue of C$286.00 million during the quarter. Boralex had a negative net margin of 3.56% and a negative return on equity of 2.08%. Sell-side analysts expect that Boralex Inc. will post 1.3383764 EPS for the current fiscal year. 

## Boralex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 15th were issued a $0.165 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $0.66 annualized dividend and a dividend yield of 1.8%. Boralex's payout ratio is presently -212.90%. 

## About Boralex

(Get Free Report)

Boralex Inc is an electric utility company involved in the development, construction, and operation of renewable energy power facilities. The company controls a portfolio of electricity producing plants that utilize wind, hydroelectric, thermal, and solar fuel sources. Most of Boralex's plants rely on wind power, while a significant number also employ hydroelectric power. The company generates the vast majority of its revenue from the sale of energy through long-term contracts to customers in Canada, France, and the United States.

## Read More

-   Five stocks we like better than Boralex
-   System Upgrade: First Internet Bancorp Options Surge
-   AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
-   The AI Chip Blockade Is Creating a Shadow Market
-   Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.*

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source
## Should You Invest $1,000 in Boralex Right Now?

Before you consider Boralex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Boralex wasn't on the list.

While Boralex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [RJF.US](https://longbridge.com/en/quote/RJF.US.md)
- [INBK.US](https://longbridge.com/en/quote/INBK.US.md)
- [MSFT.US](https://longbridge.com/en/quote/MSFT.US.md)
- [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md)
- [GRAB.US](https://longbridge.com/en/quote/GRAB.US.md)
- [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md)
- [GRABW.US](https://longbridge.com/en/quote/GRABW.US.md)

## Related News & Research

- [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md)
- [Kenny Choi Sells 50,000 Shares of Belo Sun Mining (TSE:BSX) Stock](https://longbridge.com/en/news/296763306.md)
- [Keyera Corp. (TSE:KEY) Receives Consensus Rating of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/296575951.md)
- [First Trust Global Risk Managed Inc Index ETF declares CAD 0.05 dividend](https://longbridge.com/en/news/296824765.md)
- [Frontera Energy (TSE:FEC) Insider Sells 1,400 Shares](https://longbridge.com/en/news/296821150.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**